Fed up of endless wait?
Look for clinic with Prime
Dr. Cesar Rodriguez Valdes
Dr. Cesar  Rodriguez Valdes Internal Medicine in New-York

Dr. Cesar Rodriguez Valdes

Claim this profile

Residency - ID, Fellowship 2, Residency in Internal Medicine

Internal Medicine,
Hematologic Oncologist
21 Years Experience Overall

Medical Registration Verified

Dr. Cesar Rodriguez Valdes is a Internal Medicine,Hematologist and Oncologist in New York 10029, New York and has an experience of 21 years in these fields. Dr. Cesar Rodriguez Valdes practices at Beth Israel Medical Center in New York 10029, New York and The Blavatnik Family Chelsea Medical Center At Mount Sinai in New York 10029, New York. He completed Fellowship from University of Louisville School of Medicine,Residency from Texas Tech University and Medical School from Escuela De Medicina Tec De Monterrey in 2003. He is a member of International Myeloma Working Group. Some of the services provided by the doctor are: Monoclonal Gammopathy of Uncertain Significance (MGUS),AL Amyloidosis,Thyroid cancer Treatment,Chronic Myeloid Leukemia (CML) and Plasmapheresis etc.

This platform is intended for use by patients with commercial insurance or who are paying for healthcare services directly (self-pay). It is not available for patients covered by Medicare, Medicaid, or other federal healthcare programs.

104 Surgeries & Treatments

treatment of anemia, clotting disorders and blood cancers such as leukemia and lymphoma

treatment of anemia, clotting disorders and blood cancers such as leukemia and lymphoma

diagnosing, treating and managing diseases originating in the blood, bone marrow and lymph

diagnosing, treating and managing diseases originating in the blood, bone marrow and lymph

3D organoid model research

3D organoid model research

immunotherapies including T cell and NK cell therapies

immunotherapies including T cell and NK cell therapies

monoclonal gammopathy of undetermined significance (MGUS)

monoclonal gammopathy of undetermined significance (MGUS)

treating patients with plasma cell disorders including multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS)

treating patients with plasma cell disorders including multiple myeloma, AL amyloidosis, POEMS syndrome, plasma cell leukemia, and monoclonal gammopathy of undetermined significance (MGUS)

Smoldering Myaloma

Smoldering Myaloma

Plasma Cell Neoplasms

Plasma Cell Neoplasms

Monoclonal Gammopathy of Uncertain Significance (MGUS)

Monoclonal Gammopathy of Uncertain Significance (MGUS)

Early Drug Development

Early Drug Development

Pick a time slot

Clinic Appointment
Beth Israel Medical Center
Change Clinic
0
New York 10029